Ferritin Testing Market Growth and Recent Trends by 2031

Coverage: By Indication (Anemia, Hemochromatosis, Pregnancy, and Lead Poisoning) and End User (Hospitals, Diagnostic Laboratories, and Specialty Clinics), and Geography

Historic Data: 2021-2022 | Base Year: 2021 | Forecast Period: 2024-2031
  • Status : Data Released
  • Report Code : TIPRE00008620
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 16, 2024
Ferritin Testing Market Growth and Recent Trends by 2031
Report Date: May 16, 2024   |   Report Code: TIPRE00008620 Email: sales@theinsightpartners.com

2021 Market Size

US$ 405.24 Mn

Base year value

2031 Forecast

US$ 670.74 Mn

Projected by 2031

CAGR 2024-2031

5.3 %

Growth rate

Addressable Market

US$ 5,442.97 Mn

(2024-2031)

The Ferritin testing market size in 2021 stood at US$ 405.24 million and is projected to reach US$ 670.74 million by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 5.3% in 2023–2031. Availability of advanced technologies such as the integration of AI and ML are likely to remain key ferritin testing market trends.

Ferritin Testing Market Analysis

The growing iron deficiency disorders and the increasing burden of anemia in youngsters is one of the major driving factors for the ferritin testing market growth. Moreover, the high prevalence of blood disorders in the geriatric population, combined with an expanding geriatric population, is likely to raise the global burden of blood disorders, boosting demand for ferritin test equipment and driving market growth.

Ferritin Testing Market Overview

Ferritin test determine the level of iron in the blood, which is further used in the diagnosis of iron deficiency. The rising prevalence of anemia, malnutrition, and aging population is driving the demand of ferritin testing. In anemia patient lacks the adequate quantity of red blood cells, to supply sufficient amount of oxygen to the body's tissue. The ferritin test detect total iron-binding capacity test, or blood cell counts and the iron level.

Market Research Highlights

  • Global market for Ferritin Testing was valued at US$ 405.24 Million in 2021
  • Annual market size is expected to reach US$ 670.74 Million by 2031
  • Total addressable market (TAM) during 2024-2031 is projected to reach approximately US$ 5,442.97 Million
  • Market is anticipated to register a CAGR of 5.3% during the forecast period
  • The United States represents a key market, supported by Growing Burden of Iron Deficiency Disorders, Increasing Prevalence of Iron Deficiency in Aging Population, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Government Initiatives to Reduce Anemia Burden Worldwide are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Eurolyser Diagnostica GmbH,, Cortez Diagnostics Inc,, bioMÁrieux SA,, Doctorcall,, Aviva Systems Biology Corporation,, Biopanda Reagents Ltd,, Monobind Inc,, Orgentec Diagnostika,, Thermo Fisher Scientific Inc,, Sekisui Diagnostic, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Ferritin Testing Market: Strategic Insights

ferritin-testing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Ferritin Testing Market Drivers and Opportunities

Increasing Prevalence of Iron Deficiency in Aging Population to Favor Market Growth

The older population is likely to suffer more from iron deficiencies, such as anemia. The common causes of anemia in the old population are chronic disease and iron deficiency. Apart from this, Vitamin B12 deficiency, folate deficiency, and gastrointestinal bleeding also cause anemia in the old population. The chances of anemia prevalence increase with advancing age. As per the NCBI, anemia occurs in more than 10% of people over 65 age, and in more than 50% of individuals who are older than the age of 80. The geriatric population is increasing worldwide. For instance, according to OCHA, the global population aged 65 years or over is projected to rise by 6% in 2050. Thus, increasing prevalence of iron deficiency in the aged population is expected to boost the demand for ferritin testing..

Government Initiatives to Reduce Anemia Burden Worldwide

Anemia is one of the most serious global public health problems. As per the WHO, it affects over half of the pre-school children and pregnant women in developing countries and at least 30–40% in industrialized countries. In low-income countries, anemia is one of the major causes of deaths in children under five years and pregnant women. Reducing the burden of anemia would make a major contribution to reducing malnutrition globally. Many countries are running several programs to reduce the burden of anemia. For instance, Indian government is running several programs, including Integrated Child Development Scheme, National Nutritional Anemia Control Program, Weekly Iron and Folic Acid Supplementation, and National Iron Plus Initiative, to combat anemia. The Anemia Mukt Bharat is focusing on reducing anemia from 50% in 2016 to 32% by 2022 amongst pregnant women. Such initiatives increase awareness regarding iron deficiency and increase adoption of testing practices.

Ferritin Testing Market Report Segmentation Analysis

Key segments that contributed to the derivation of the ferritin testing market analysis are indication and end user.

  • Based on indication, the ferritin testing market is divided into anemia, hemochromatosis, pregnancy, and lead poisoning. Anemia segment held a largest market share in 2023.
  • In terms of end user, the market is segmented into hospitals, diagnostic laboratories, and specialty clinics. The hospitals segment dominated the market in 2023.

Ferritin Testing Market Share Analysis by Geography

The geographic scope of the ferritin testing market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the ferritin testing market. The increasing aging population and its associated iron deficiency disorders and rapidly developing healthcare facilities across the region are factors contributing to the dominance of the North America ferritin testing market. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Ferritin Testing Market Report Scope

Report Attribute Details
Market size in 2021 US$ 405.24 Million
Market Size by 2031 US$ 670.74 Million
Global CAGR (2023 - 2031) 5.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Indication
  • Anemia
  • Hemochromatosis
  • Pregnancy
  • Lead Poisoning
By End User
  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Eurolyser Diagnostica GmbH,
  • Cortez Diagnostics Inc,
  • bioMérieux SA,
  • Doctorcall,
  • Aviva Systems Biology Corporation,
  • Biopanda Reagents Ltd,
  • Monobind Inc,
  • Orgentec Diagnostika,
  • Thermo Fisher Scientific Inc,
  • Sekisui Diagnostic

Ferritin Testing Market Players Density: Understanding Its Impact on Business Dynamics

The Ferritin Testing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

ferritin-testing-market-cagr

Ferritin Testing Market News and Recent Developments

The ferritin testing market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for ferritin testing:

  • WCBS will be implementing ferritin testing in all blood donors during the course of 2022. Iron deficiency is known to be a relatively common complication of regular blood donation, so this initiative hopes to identify these donors, advise them to seek medical attention and defer them from donating for a specified period of time. (Source: Western Cape Blood Service, Press Release, 2022)

Ferritin Testing Market Report Coverage and Deliverables

The “Ferritin Testing Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA